Mitsubishi UFJ Asset Management
TBIO

Mitsubishi UFJ Asset Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-17,746
Closed -$489K – 1132
2021
Q2 		$489K Sell
17,746
-3,354
-16% -$65.9K ﹤0.01% 959
2021
Q1 		$348K Buy
21,100
+7,392
+54% +$168K ﹤0.01% 939
2020
Q4 		$253K Buy
13,708
+4,483
+49% +$80.2K ﹤0.01% 929
2020
Q3 		$126K Sell
9,225
-293
-3% -$4.52K ﹤0.01% 941
2020
Q2 		$171K Sell
9,518
-7,238
-43% -$109K ﹤0.01% 908
2020
Q1 		$167K Buy
16,756
+3,815
+29% +$31.3K ﹤0.01% 869
2019
Q4 		$97K Buy
+12,941
New +$119K ﹤0.01% 955

Mitsubishi UFJ Asset Management's TBIO Position: Q3 2021 in Review

Mitsubishi UFJ Asset Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 17,746 shares — an estimated $489K sold.

Mitsubishi UFJ Asset Management first reported a position in TBIO in Q4 2019 and held it in 7 quarters. The position peaked at $489K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Mitsubishi UFJ Asset Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 17,746 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $489K.
  • Mitsubishi UFJ Asset Management first reported a position in Translate Bio, Inc. Common Stock in Q4 2019 and held it in 7 quarters.
  • Mitsubishi UFJ Asset Management's Translate Bio, Inc. Common Stock position peaked at $489K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q3 2021, filed 4 Nov 2021.